<DOC>
	<DOCNO>NCT01248351</DOCNO>
	<brief_summary>The objective study test hypothesis whether autologous store platelet able offset antiplatelet effect aspirin clopidogrel assess state-of-the-art platelet function assay .</brief_summary>
	<brief_title>Reversibility Dual Antiplatelet Therapy Platelets</brief_title>
	<detailed_description>Dual antiplatelet therapy aspirin clopidogrel well establish strategy prevent thrombotic complication patient high platelet reactivity follow plaque rupture acute coronary syndrome ( ACS ) percutaneous coronary intervention . Current practice guideline antiplatelet therapy advocate one 12 month dual antiplatelet therapy bare metal stent PCI 12 month dual antiplatelet therapy PCI patient ACS drug elute stent PCI . Although oral antiplatelet therapy associate , short- well long-term clinical efficacy , irreversible platelet inhibition carry substantial risk bleed particularly patient present surgery . Empiric therapy bleeding consist platelet transfusion . However , currently pharmacodynamic study assess effect store platelet in-vitro platelet function test . Healthy volunteer donate platelet , take aspirin clopidogrel 3 day ( load dose aspirin 300 mg , clopidogrel 300 mg , maintenance dose aspirin 100 mg , clopidogrel 75 mg ) platelet retransfused 4th day . Pharmacodynamic measurement platelet function perform baseline , drug intake retransfusion , immediately retransfusion 24 hour thereafter .</detailed_description>
	<criteria>1 . Informed consent 2 . Healthy volunteer , male female ( exclusion pregnancy birth control pill contraceptive coil implant ) 3 . Age consent 4 . Weight : 70 kg 100 kg 5 . Platelet count 240 000 440 000/µL 6 . Hematocrit &gt; 40 % 7. readiness refrain activity prone injury study period . Exclusion criterion : 1 . Allergy aspirin clopidogrel 2 . History bleed 3 . History peptic ulcer 4 . Intake aspirin NSAR last ten day screen 5 . Gastrointestinal disease preclude resorption aspirin clopidogrel 6 . Scheduled surgery 7 . Any current medication 8 . History hepatic disease 9 . 20µm ADP induced aggregation &lt; 60 % screen 10 . CYP2C19 polymorphisms 11 . Donation blood within precede 4 week 12 . Neurotic disease 13 . Current smoking 14 . Drug addiction 15 . Intake grapefruit last 10 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>aspirin , clopidogrel , pharmacodynamics , platelet transfusion</keyword>
</DOC>